… To summarize the metabolic alterations associated with androgen deprivation therapy (ADT)
for prostate cancer and to evaluate the evidence linking ADT with an increased risk of diabetes …

… of treatment for advanced and metastatic disease. In the state of metastatic disease, androgen
suppression is a palliative treatment … Although androgen suppression therapy may be …

… androgen suppression and serum prostate … androgen suppression therapy for patients
with biochemical recurrences following radiation therapy for clinically localized prostate cancer. …

… Androgen deprivation therapy (ADT) has broad application in the treatment of prostate cancer
… Increasing use of ADT for PC, longer timeframe for treatment (increased uptake of PSA …

… Androgen deprivation therapy (ADT) to treat prostate cancer may be associated with an …
literature on the association of ADT for the treatment of prostate cancer with dementia risk. …

… Ever since, androgen deprivation therapy (ADT) has been the important treatment of
advanced prostate cancer. Androgen deprivation can also be achieved by chemical castration, …

… prostate cancer who undergo hormonal suppression therapy … in the first year after androgen
deprivation was initiated. The … , men with prostate cancer and no androgen deprivation and …

… of the following keywords: prostate cancer or prostate tumor or prostate carcinoma, androgen
and deprivation or androgen suppression or endocrine treatment; and cardiovascular or …

… Androgen receptor (AR) signaling is a critical survival pathway for prostate cancer cells, and
androgen-deprivation therapy (ADT) remains the principal treatment for patients with locally …

… hormonal treatment for prostate cancer and its possible cardiovascular adverse effects. We
found consistent evidence that this treatment may increase the risk of cardiovascular disease. …